Diabetes mellitus and foetus development;Diabetes mellitus a vývoj plodu

Diabetologie Metabolismus Endokrinologie Vyziva

Volumn 5, Issue 3, 2002, Pages 148-152

  Maňáková, Eva ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Birth defects; Diabetes mellitus; Pregnancy

Indexed keywords

CHLORPROPAMIDE; GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; TROGLITAZONE;

ABORTION; ARTICLE; BIRTH DEFECT; CARDIOVASCULAR MALFORMATION; CAUDAL REGRESSION SYNDROME; CENTRAL NERVOUS SYSTEM MALFORMATION; DIABETES MELLITUS; FEMALE; FETUS; FETUS DEVELOPMENT; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; INCIDENCE; MORPHOGENESIS; PERINATAL MORTALITY; PREGNANCY TERMINATION; PREVENTIVE MEDICINE; PROGENY; SPONTANEOUS ABORTION; TERATOGENESIS;

EID: 0036388290     PISSN: 12119326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Amri K, Freund N, Duong Van Huyen JP, Merlet-Benichou C, Lelievre-Pegorier M. Altered nephrogenesis due to maternal diabetes is associated with increased expression of IGF-II/ mannose-6-phosphate receptor in fetal kidney. Diabetes 2001; 50(5): 1069-1075.
2. Bauman WA, Yalow RS. Transplacental passage of insulin complexed to antibody. Proc Natl Acad Sci USA 1981; 78(7): 4588-4590.
3. Cederberg J, Basu S, Eriksson UJ. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 2001; 44: 766-774.
4. Coetzee EJ, Jackson WP. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med J 1984; 65: 635-637.
5. Fine EL, Horal M, Chang TI, Fortin G, Loeken MR. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes 1999; 48(12): 2454-2462.
6. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome safely reduces first trimester miscarriage from 64 % to 5 % without teratogenicity. J Investig Med 2000; 48 (5): 263A.
7. Greene MF. Prevention and diagnosis of congenital anomalies in diabetic pregnancies. Clinics in perinatology 1993; 20(3): 533-547.
8. Hellmuth E, Damm P, Molsted-Pedersen L. Congenital malformations in offspring of diabetic women treated with oral hypoglycaemic agents during embryogenesis. Diabetic Medicine 1994; 11: 471-474.
9. Hellmuth E, Damm P, Molsted-Pedersen L, Bendtson I. Prevalence of noctural hypoglycemia in first trimester of pregnancy in patients with insulin treated diabetes mellitus. Acta Obst Gynecol Scand 2000; 79(11): 958-962.
10. Hendricks KA, Nuno OM, Suarez L, Larsen R. Effect of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology 2001; 12(6): 630-635.
11. Jaeggi ET, Fouron JC, Proulx F. Fetal cardiac performance in uncomplicated and well-controlled maternal type I diabetes. Ultrasound Obstet Gynecol 2001; 17(4): 311-315.
12. Julian D, Abbott UK. An avian model for comparative studies of insulin teratogenicity. Anat Histol Embryol 1998; 27(5): 313-321.
13. Kučera J. Rate and type of congenital anomalies among offsprings of diabetic women. J Repro Med 1971; 7: 61-70.
14. Langer O, Conway D, Berkus M, Xenakis EM. There is no association between oral hypoglycemic use and fetal anomalies. Am J Obstet Gynecol 1999; 180 (Supl.2): 38.
15. Leonard CM, Bergman M, Frenz DA, Macreery LA, Newman SA. Abnormal ambient glucose levels inhibit proteoglycan core protein gene expression and reduce proteoglycan accumulation during chondrogenesis: Possible mechanism for teratogenic effect of maternal diabetes. Proc Natl Acad Sci USA 1989; 86: 10113-10117.
16. Lien YH, Tseng MN, Stern R. Glucose and glucose analogs modulate collagen metabolism. Exp Mol Pathol 1992; 57(3): 215-221.
17. Martínez-Fríaz ML, Bermejo E, Rodríguez-Pinilla E, Prieto L, Fríaz JL. Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. Am J Medical genetics 1998; 78: 140-145.
18. McCarthy AD, Etcheverry SB, Cortizo AM. Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development. Acta Diabetol.2001; 38: 113-122.
19. Menon RK, Cohen RM, Sperling MA, Cutfield WS, Mimouni F, Khoury JC. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia. N Engl J Med 1990; 323(5): 309-315.
20. Ornoy A, Zaken V, Kohen R. Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: Reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies. Teratology 1999; 60: 376-386.
21. Rosenn BM, Miodovnik M, Holcberg G, Khoury JC, Siddiqi TA. Hypoglycemia: price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995; 85(3): 417-422.
22. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 1999; 6(5): 347-363.
23. Towner D, Kjos SI, Leung B, Montoro MM, Xiang A, Mestman JH, Buchanan TA. Congenital malformations in pregnancies complicated by NIDDM. Diabetic Care 1995; 18(11): 1446-1450.
24. Tuchmann-Duplessis H., Mercier-Parot L. Repercussions dur la gestation et le development foetal du rat d 'un hypoglycemiant le chlorhydrate de N,N-dimethylbiguanide. CR Acad Sci (Paris) 1961; 253: 321-323.
25. Webb PJ, Streck RD. Rat fetal expression of peroxisome proliferator-activated receptor (PPAR) genes, PPAR-regulated genes a retinoid X receptor genes. Teratology 1998; 57 (4/5): 233.
26. Weiss PA, Kainer F, Purstner R, Zehetleiner G, Huttner U, Haas J. Anti-insulin antibodies and birth weight in pregnancies complicated by diabetes. Early Hum Dev 1998; 53(2): 145-154.
27. Wentzel P, Wentzel CR, Gareskog MB, Erikson UJ. Introduction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. Teratology 2001; 63(5): 193-201.
28. Wiznitzer A, Furman B, Mazor M, Reece EA. The role of prostanoids in the development of diabetic embryopathy. Semin Reprod Endocrinol 1999; 17(2): 175-181.
29. ÚZIS. Péče o nemocné cukrovkou v České republice v roce 2000. In: (http://www.uzis.cz):